Estrella Immunopharma (ESLAW) Stock Chart & Stock Price History $0.04 -0.01 (-14.83%) As of 08/21/2025 09:52 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock Estrella Immunopharma Stock Price Performance The Estrella Immunopharma (ESLAW) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 57.46%, with a year-to-date return of -53.75%. In the past month, the stock has increased 0.47%, reflecting recent market activity. As of the latest close, Estrella Immunopharma traded at $0.04 with a market cap of and volume of 540 shares. Receive ESLAW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+5.20%1 Month Performance+0.47%3 Month Performance+5.46%Year-To-Date Performance-53.75%1 Year Performance-57.46% ESLAW Stock Chart for Friday, August, 22, 2025 ESLAW Chart by TradingView Estrella Immunopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/21/2025$0.05$0.04-14.83%$0.04$0.04540 shs$0.0008/20/2025$0.05$0.05-4.95%$0.05$0.0536,021 shs$0.0008/19/2025$0.04$0.05+17.98%$0.05$0.035,000 shs$0.0008/18/2025$0.04$0.04+10.15%$0.04$0.0431,400 shs$0.0008/15/2025$0.04$0.04+8.31%$0.04$0.043,055 shs$0.0008/14/2025$0.04$0.04-6.75%$0.04$0.04300 shs$0.0008/13/2025$0.04$0.04+7.53%$0.04$0.04350 shs$0.0008/12/2025$0.04$0.04$0.04$0.04200 shs$0.0008/11/2025$0.04$0.04$0.04$0.04200 shs$0.0008/08/2025$0.04$0.04+1.09%$0.04$0.04240 shs$0.00 Get the Latest News and Ratings for ESLAW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. 08/07/2025$0.04$0.04$0.04$0.043,000 shs$0.0008/06/2025$0.04$0.04+1.66%$0.04$0.043,062 shs$0.0008/05/2025$0.04$0.04$0.05$0.03160,695 shs$0.0008/04/2025$0.05$0.04-19.73%$0.05$0.03160,695 shs$0.0008/01/2025$0.05$0.05$0.05$0.0438,097 shs$0.0007/31/2025$0.05$0.05$0.05$0.0438,097 shs$0.0007/30/2025$0.03$0.05+39.63%$0.05$0.0438,097 shs$0.0007/29/2025$0.04$0.03-23.58%$0.03$0.03425 shs$0.0007/28/2025$0.04$0.04$0.04$0.044,800 shs$0.0007/25/2025$0.04$0.04$0.04$0.044,800 shs$0.0007/24/2025$0.04$0.04-0.09%$0.04$0.044,800 shs$0.0007/23/2025$0.04$0.04$0.04$0.044,800 shs$0.0007/22/2025$0.04$0.04$0.04$0.044,800 shs$0.0007/21/2025$0.04$0.04+9.02%$0.04$0.044,800 shs$0.00 Related Companies 180 Life Sciences Stock Chart 60 Degrees Pharmaceuticals Stock Chart Alpha Tau Medical Stock Chart Apollomics Stock Chart BriaCell Therapeutics Stock Chart Cardio Diagnostics Stock Chart Celularity Stock Chart CERo Therapeutics Stock Chart Cingulate Stock Chart Clene Stock Chart Receive ESLAW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ESLAW) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Estrella Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Estrella Immunopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access